{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T22:28:29Z","timestamp":1772749709248,"version":"3.50.1"},"reference-count":77,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.vaccine.2013.07.050","type":"journal-article","created":{"date-parts":[[2013,8,3]],"date-time":"2013-08-03T03:15:27Z","timestamp":1375499727000},"page":"1588-1594","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Current status and prospects for development of a vaccine against Trichomonas vaginalis infections"],"prefix":"10.1016","volume":"32","author":[{"given":"Jeffrey","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary E.","family":"Garber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.07.050_bib0005","series-title":"Prevalence and incidence of selected sexually transmitted infections. Chlamydia trachomatis, Neisseria gonorrhoeae, syphilis and Trichomonas vaginalis: methods and results used by WHO to generate 2005 estimates","author":"World Health Organization","year":"2011"},{"key":"10.1016\/j.vaccine.2013.07.050_bib0010","series-title":"Global incidence and prevalence of selected curable sexually transmitted infections \u2013 2008","author":"World Health Organization","year":"2012"},{"key":"10.1016\/j.vaccine.2013.07.050_bib0015","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/infdis\/71.2.127","article-title":"Experimental human vaginal trichomoniasis","author":"Hesseltine","year":"1942","journal-title":"Journal of Infectious Diseases"},{"issue":"5","key":"10.1016\/j.vaccine.2013.07.050_bib0020","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/clinids\/23.5.1075","article-title":"Clinical and microbiological correlates of vaginal trichomoniasis during pregnancy","volume":"23","author":"Pastorek","year":"1996","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1016\/j.vaccine.2013.07.050_bib0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1086\/511144","article-title":"Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention","volume":"44","author":"Se\u00f1a","year":"2007","journal-title":"Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America"},{"issue":"4","key":"10.1016\/j.vaccine.2013.07.050_bib0030","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/jama.1989.03420040109029","article-title":"Clinical manifestations of vaginal trichomoniasis","volume":"261","author":"W\u00f8lner-Hanssen","year":"1989","journal-title":"The Journal of the American Medical Association"},{"issue":"1","key":"10.1016\/j.vaccine.2013.07.050_bib0035","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jri.2009.08.007","article-title":"Impact of T. vaginalis infection on innate immune responses and reproductive outcome","volume":"83","author":"Fichorova","year":"2009","journal-title":"Journal of Reproductive Immunology"},{"issue":"1","key":"10.1016\/j.vaccine.2013.07.050_bib0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/OLQ.0b013e318186decf","article-title":"Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding","volume":"36","author":"Kissinger","year":"2009","journal-title":"Sexually Transmitted Diseases"},{"issue":"4","key":"10.1016\/j.vaccine.2013.07.050_bib0045","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1086\/338399","article-title":"Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus","volume":"34","author":"Moodley","year":"2002","journal-title":"Clinical Infectious Diseases"},{"issue":"4","key":"10.1016\/j.vaccine.2013.07.050_bib0050","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1086\/526496","article-title":"Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women","volume":"197","author":"Van Der Pol","year":"2008","journal-title":"Journal of Infectious Diseases"},{"issue":"4","key":"10.1016\/j.vaccine.2013.07.050_bib0055","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/1047-2797(94)00101-X","article-title":"Trichomonas vaginalis and cervical cancer: a prospective study in China","volume":"5","author":"Zhang","year":"1995","journal-title":"Annals of Epidemiology"},{"issue":"2","key":"10.1016\/j.vaccine.2013.07.050_bib0060","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00007435-199503000-00003","article-title":"Trichomoniasis in men: old issues and new data","volume":"22","author":"Krieger","year":"1995","journal-title":"Sexually Transmitted Diseases"},{"issue":"11","key":"10.1016\/j.vaccine.2013.07.050_bib0065","doi-asserted-by":"crossref","first-page":"844","DOI":"10.7326\/0003-4819-118-11-199306010-00003","article-title":"Clinical manifestations of trichomoniasis in men","volume":"118","author":"Krieger","year":"1993","journal-title":"Annals of Internal Medicine"},{"issue":"11","key":"10.1016\/j.vaccine.2013.07.050_bib0070","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1128\/JCM.00952-06","article-title":"Methods for detection of Trichomonas vaginalis in the male partners of infected women: implications for control of trichomoniasis","volume":"44","author":"Hobbs","year":"2006","journal-title":"Journal of Clinical Microbiology"},{"issue":"3","key":"10.1016\/j.vaccine.2013.07.050_bib0075","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1086\/376558","article-title":"High rates of Trichomonas vaginalis among men attending a sexually transmitted diseases clinic: implications for screening and urethritis management","volume":"188","author":"Schwebke","year":"2003","journal-title":"Journal of Infectious Diseases"},{"issue":"7","key":"10.1016\/j.vaccine.2013.07.050_bib0080","first-page":"873","article-title":"Diagnosis and treatment of urethritis in men","volume":"81","author":"Brill","year":"2010","journal-title":"American Family Physician"},{"issue":"4","key":"10.1016\/j.vaccine.2013.07.050_bib0085","first-page":"251","article-title":"Natural history of trichomonal infection in males","volume":"39","author":"Weston","year":"1963","journal-title":"British Journal of Venereal Diseases"},{"issue":"1","key":"10.1016\/j.vaccine.2013.07.050_bib0090","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00430-011-0205-2","article-title":"High detection rate of Trichomonas vaginalis in benign hyperplastic prostatic tissue","volume":"201","author":"Mitteregger","year":"2012","journal-title":"Medical Microbiology and Immunology"},{"issue":"6","key":"10.1016\/j.vaccine.2013.07.050_bib0095","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00007435-199707000-00008","article-title":"Trichomonas vaginalis associated with low birth weight and preterm delivery","volume":"24","author":"Cotch","year":"1997","journal-title":"Sexually Transmitted Diseases"},{"issue":"6","key":"10.1016\/j.vaccine.2013.07.050_bib0100","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1155\/S1064744995000160","article-title":"Trichomonas vaginalis weakens human amniochorion in an in vitro model of premature membrane rupture","volume":"2","author":"Draper","year":"1995","journal-title":"Infectious Diseases in Obstetrics and Gynecology"},{"issue":"5","key":"10.1016\/j.vaccine.2013.07.050_bib0105","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/0002-9378(95)90640-1","article-title":"Elevated protease activities in human amnion and chorion correlate with preterm premature rupture of membranes","volume":"173","author":"Draper","year":"1995","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"3","key":"10.1016\/j.vaccine.2013.07.050_bib0110","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1086\/515366","article-title":"Cysteine proteases of Trichomonas vaginalis degrade secretory leukocyte protease inhibitor","volume":"178","author":"Draper","year":"1998","journal-title":"Journal of Infectious Diseases"},{"issue":"1","key":"10.1016\/j.vaccine.2013.07.050_bib0115","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1172\/JCI118056","article-title":"Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro","volume":"96","author":"McNeely","year":"1995","journal-title":"Journal of Clinical Investigation"},{"issue":"1","key":"10.1016\/j.vaccine.2013.07.050_bib0120","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/QCO.0b013e3282f3d999","article-title":"Global epidemiology and control of Trichomonas vaginalis","volume":"21","author":"Johnston","year":"2008","journal-title":"Current Opinion in Infectious Diseases"},{"issue":"7","key":"10.1016\/j.vaccine.2013.07.050_bib0125","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMoa003329","article-title":"Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection","volume":"345","author":"Klebanoff","year":"2001","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1016\/j.vaccine.2013.07.050_bib0130","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/OLQ.0b013e3181cfcc4b","article-title":"Epidemiological synergy of Trichomonas vaginalis and HIV in Zimbabwean and South African women","volume":"37","author":"Mavedzenge","year":"2010","journal-title":"Sexually Transmitted Diseases"},{"issue":"4","key":"10.1016\/j.vaccine.2013.07.050_bib0135","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1086\/526498","article-title":"Trichomonas vaginalis infection: can we afford to do nothing?","volume":"197","author":"McClelland","year":"2008","journal-title":"Journal of Infectious Diseases"},{"issue":"9","key":"10.1016\/j.vaccine.2013.07.050_bib0140","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/OLQ.0b013e3182593839","article-title":"Modeling the impact of Trichomonas vaginalis infection on HIV transmission in HIV-infected individuals in medical care","volume":"39","author":"Quinlivan","year":"2012","journal-title":"Sexually Transmitted Diseases"},{"issue":"7","key":"10.1016\/j.vaccine.2013.07.050_bib0145","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1128\/IAI.73.7.4155-4160.2005","article-title":"Trichomonas vaginalis-induced epithelial monolayer disruption and human immunodeficiency virus type 1 (HIV-1) replication: implications for the sexual transmission of HIV-1","volume":"73","author":"Guenthner","year":"2005","journal-title":"Infection and Immunity"},{"issue":"2","key":"10.1016\/j.vaccine.2013.07.050_bib0150","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1600-0897.2010.00902.x","article-title":"Innate immunity and inflammatory response to Trichomonas vaginalis and bacterial vaginosis: relationship to HIV acquisition","volume":"65","author":"Thurman","year":"2010","journal-title":"American Journal of Reproductive Immunology"},{"issue":"9","key":"10.1016\/j.vaccine.2013.07.050_bib0155","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/OLQ.0b013e3181d877b7","article-title":"Etiology and STI\/HIV coinfections among patients with urethral and vaginal discharge syndromes in South Africa","volume":"37","author":"Mhlongo","year":"2010","journal-title":"Sexually Transmitted Diseases"},{"issue":"2","key":"10.1016\/j.vaccine.2013.07.050_bib0160","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3923\/ijtmed.2010.24.27","article-title":"The prevalence of Trichomonas vaginalis in HIV-positive and negative patients in referral hospitals in Goiania, Goias, Brazil","volume":"5","author":"de Lemos","year":"2010","journal-title":"International Journal of Tropical Medicine"},{"key":"10.1016\/j.vaccine.2013.07.050_bib0165","article-title":"Trichomonas vaginalis infection among women receiving gynaecological care at an Alabama HIV Clinic","volume":"February","author":"Muzny","year":"2013","journal-title":"Sexually Transmitted Infections"},{"issue":"4","key":"10.1016\/j.vaccine.2013.07.050_bib0170","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S2222-1808(11)60066-2","article-title":"Trichomonas vaginalis in HIV\/AIDS subjects in Nigeria","volume":"1","author":"Nweze","year":"2011","journal-title":"Asian Pacific Journal of Tropical Disease"},{"issue":"8","key":"10.1016\/j.vaccine.2013.07.050_bib0175","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/OLQ.0b013e31825725ad","article-title":"Effect of trichomoniasis therapy on genital HIV viral burden among African women","volume":"39","author":"Anderson","year":"2012","journal-title":"Sexually Transmitted Diseases"},{"issue":"7","key":"10.1016\/j.vaccine.2013.07.050_bib0180","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1086\/651115","article-title":"Determinants of HIV type 1 shedding from genital ulcers among men in South Africa","volume":"50","author":"Paz-Bailey","year":"2010","journal-title":"Clinical Infectious Diseases"},{"issue":"7","key":"10.1016\/j.vaccine.2013.07.050_bib0185","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1086\/319287","article-title":"The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1","volume":"183","author":"Wang","year":"2001","journal-title":"Journal of Infectious Diseases"},{"issue":"RR-12","key":"10.1016\/j.vaccine.2013.07.050_bib0190","first-page":"1","article-title":"Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010","volume":"59","author":"Workowski","year":"2010","journal-title":"MMWR \u2013 Recommendations and Reports"},{"issue":"4","key":"10.1016\/j.vaccine.2013.07.050_bib0195","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/sj.cr.7290169","article-title":"Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis","volume":"13","author":"Dunne","year":"2003","journal-title":"Cell Research"},{"issue":"6","key":"10.1016\/j.vaccine.2013.07.050_bib0200","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3201\/eid1806.111590","article-title":"Trichomonas vaginalis antimicrobial drug resistance in 6 US cities, STD Surveillance Network, 2009\u20132010","volume":"18","author":"Kirkcaldy","year":"2012","journal-title":"Emerging Infectious Diseases"},{"issue":"7","key":"10.1016\/j.vaccine.2013.07.050_bib0205","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/OLQ.0b013e3181cfcd8c","article-title":"Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population","volume":"37","author":"Krashin","year":"2010","journal-title":"Sexually Transmitted Diseases"},{"issue":"12","key":"10.1016\/j.vaccine.2013.07.050_bib0210","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1128\/AAC.00814-06","article-title":"Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole","volume":"50","author":"Schwebke","year":"2006","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"1","key":"10.1016\/j.vaccine.2013.07.050_bib0215","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1128\/CMR.14.1.150-164.2001","article-title":"Drug targets and mechanisms of resistance in the anaerobic protozoa","volume":"14","author":"Upcroft","year":"2001","journal-title":"Clinical Microbiology Reviews"},{"issue":"1","key":"10.1016\/j.vaccine.2013.07.050_bib0220","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1086\/653443","article-title":"Observation of probable persistent, undetected Trichomonas vaginalis infection among HIV-positive women","volume":"51","author":"Gatski","year":"2010","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"10.1016\/j.vaccine.2013.07.050_bib0225","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1086\/595706","article-title":"Persistent, undetected Trichomonas vaginalis infections?","volume":"48","author":"Peterman","year":"2009","journal-title":"Clinical Infectious Diseases"},{"issue":"5","key":"10.1016\/j.vaccine.2013.07.050_bib0230","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/OLQ.0b013e318203e3ce","article-title":"Changing sexually transmitted infection screening protocol will result in improved case finding for Trichomonas vaginalis among high-risk female populations","volume":"38","author":"Roth","year":"2011","journal-title":"Sexually Transmitted Diseases"},{"issue":"2","key":"10.1016\/j.vaccine.2013.07.050_bib0235","doi-asserted-by":"crossref","first-page":"188e1","DOI":"10.1016\/j.ajog.2008.10.005","article-title":"Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women","volume":"200","author":"Nye","year":"2009","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2","key":"10.1016\/j.vaccine.2013.07.050_bib0240","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1086\/518851","article-title":"Rapid antigen testing compares favorably with transcription-mediated amplification assay for the detection of Trichomonas vaginalis in young women","volume":"45","author":"Huppert","year":"2007","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"10.1016\/j.vaccine.2013.07.050_bib0245","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1128\/JCM.01547-12","article-title":"Performance of a rapid self-test for detection of Trichomonas vaginalis in South Africa and Brazil","volume":"51","author":"Jones","year":"2013","journal-title":"Journal of Clinical Microbiology"},{"key":"10.1016\/j.vaccine.2013.07.050_bib0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.micinf.2012.09.004","article-title":"The effects of environmental factors on the virulence of Trichomonas vaginalis","author":"Figueroa-Angulo","year":"2012","journal-title":"Microbes and Infection"},{"key":"10.1016\/j.vaccine.2013.07.050_bib0255","first-page":"536037","article-title":"Trichomoniasis and lactoferrin: future prospects","author":"Sehgal","year":"2012","journal-title":"Infectious Diseases in Obstetrics and Gynecology"},{"issue":"47","key":"10.1016\/j.vaccine.2013.07.050_bib0260","doi-asserted-by":"crossref","first-page":"40494","DOI":"10.1074\/jbc.M111.280578","article-title":"Chemical Structure of Trichomonas vaginalis surface lipoglycan: a role for short galactose (\u03b21-4\/3) N-acetylglucosamine repeats in host cell interaction","volume":"286","author":"Ryan","year":"2011","journal-title":"Journal of Biological Chemistry"},{"issue":"10","key":"10.1016\/j.vaccine.2013.07.050_bib0265","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.1128\/IAI.00631-06","article-title":"Trichomonas vaginalis lipophosphoglycan triggers a selective upregulation of cytokines by human female reproductive tract epithelial cells","volume":"74","author":"Fichorova","year":"2006","journal-title":"Infection and Immunity"},{"issue":"1","key":"10.1016\/j.vaccine.2013.07.050_bib0270","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10719-008-9157-1","article-title":"Structural details and composition of Trichomonas vaginalis lipophosphoglycan in relevance to the epithelial immune function","volume":"26","author":"Singh","year":"2009","journal-title":"Glycoconjugate Journal"},{"issue":"10","key":"10.1016\/j.vaccine.2013.07.050_bib0275","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1111\/j.1462-5822.2008.01190.x","article-title":"Galectin-1 on cervical epithelial cells is a receptor for the sexually transmitted human parasite Trichomonas vaginalis","volume":"10","author":"Okumura","year":"2008","journal-title":"Cellular Microbiology"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2013.07.050_bib0280","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.exppara.2004.05.004","article-title":"Trichomonas vaginalis: characterization of a 39-kDa cysteine proteinase found in patient vaginal secretions","volume":"107","author":"Hernandez-Gutierrez","year":"2004","journal-title":"Experimental Parasitology"},{"issue":"2","key":"10.1016\/j.vaccine.2013.07.050_bib0285","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/mpat.1995.0049","article-title":"Iron mediates Trichomonas vaginalis resistance to complement lysis","volume":"19","author":"Alderete","year":"1995","journal-title":"Microbial Pathogenesis"},{"issue":"2","key":"10.1016\/j.vaccine.2013.07.050_bib0290","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/OLQ.0b013e31827c08c3","article-title":"A Trich-y question: should Trichomonas vaginalis infection be reportable?","volume":"40","author":"Hoots","year":"2013","journal-title":"Sexually Transmitted Diseases"},{"issue":"9","key":"10.1016\/j.vaccine.2013.07.050_bib0295","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1128\/IAI.64.9.3571-3575.1996","article-title":"Inducible immunity to Trichomonas vaginalis in a mouse model of vaginal infection","volume":"64","author":"Abraham","year":"1996","journal-title":"Infection and Immunity"},{"issue":"Supp. 1","key":"10.1016\/j.vaccine.2013.07.050_bib0300","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1073\/pnas.1002611107","article-title":"Vaginal microbiome of reproductive-age women","volume":"108","author":"Ravel","year":"2011","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"6","key":"10.1016\/j.vaccine.2013.07.050_bib0305","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1128\/IAI.60.6.2375-2379.1992","article-title":"Mouse intravaginal infection with Trichomonas vaginalis and role of Lactobacillus acidophilus in sustaining infection","volume":"60","author":"McGrory","year":"1992","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.vaccine.2013.07.050_bib0310","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2307\/3283708","article-title":"Interactions between Trichomonas vaginalis and vaginal flora in a mouse model","author":"Meysick","year":"1992","journal-title":"Journal of Parasitology"},{"issue":"5","key":"10.1016\/j.vaccine.2013.07.050_bib0315","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/0093-691X(89)90479-2","article-title":"Investigations of the incidence of bovine trichomoniasis in Nevada and of the efficacy of immunizing cattle with vaccines containing Tritrichomonas foetus","volume":"31","author":"Kvasnicka","year":"1989","journal-title":"Theriogenology"},{"issue":"11","key":"10.1016\/j.vaccine.2013.07.050_bib0320","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.2460\/ajvr.1992.53.11.2023","article-title":"Clinical evaluation of the efficacy of inoculating cattle with a vaccine containing Tritrichomonas foetus","volume":"53","author":"Kvasnicka","year":"1992","journal-title":"American Journal of Veterinary Research"},{"issue":"6","key":"10.1016\/j.vaccine.2013.07.050_bib0325","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1751-0813.1983.tb05957.x","article-title":"Immunisation of bulls against trichomoniasis","volume":"60","author":"Clark","year":"1983","journal-title":"Australian Veterinary Journal"},{"issue":"2","key":"10.1016\/j.vaccine.2013.07.050_bib0330","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.vaccine.2009.10.039","article-title":"Preputial cellular and antibody responses of bulls vaccinated and\/or challenged with Tritrichomonas foetus","volume":"28","author":"Cobo","year":"2009","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2013.07.050_bib0335","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.8755-8920.2001.450507.x","article-title":"Bovine trichomoniasis as a model for development of vaccines against sexually-transmitted disease","volume":"45","author":"Corbeil","year":"2001","journal-title":"American Journal of Reproductive Immunology"},{"issue":"3","key":"10.1016\/j.vaccine.2013.07.050_bib0340","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1354\/vp.42-3-282","article-title":"Uterine mast cells and immunoglobulin-E antibody responses during clearance of Tritrichomonas foetus","volume":"42","author":"Corbeil","year":"2005","journal-title":"Veterinary Pathology Online"},{"issue":"Supp. 2","key":"10.1016\/j.vaccine.2013.07.050_bib0345","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.1093\/clinids\/21.Supplement_2.S158","article-title":"Use of an animal model of trichomoniasis as a basis for understanding this disease in women","volume":"21","author":"Corbeil","year":"1995","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.vaccine.2013.07.050_bib0350","series-title":"Trichomonads parasitic in humans","first-page":"112","article-title":"Employment of experimental animals in studies of Trichomonas vaginalis infection","year":"1990"},{"issue":"12","key":"10.1016\/j.vaccine.2013.07.050_bib0355","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/01.olq.0000218871.89901.61","article-title":"Development of a nonhuman primate model for Trichomonas vaginalis infection","volume":"33","author":"Patton","year":"2006","journal-title":"Sexually Transmitted Diseases"},{"issue":"5809","key":"10.1016\/j.vaccine.2013.07.050_bib0360","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1126\/science.1132894","article-title":"Draft genome sequence of the sexually transmitted pathogen Trichomonas vaginalis","volume":"315","author":"Carlton","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2013.07.050_bib0365","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/B978-0-12-391429-3.00006-X","article-title":"Trichomonas vaginalis pathobiology new insights from the genome sequence","volume":"77","author":"Hirt","year":"2011","journal-title":"Advances in Parasitology"},{"key":"10.1016\/j.vaccine.2013.07.050_bib0370","article-title":"Genetic diversity in Trichomonas vaginalis","volume":"May","author":"Meade","year":"2013","journal-title":"Sexually Transmitted Infections"},{"issue":"13","key":"10.1016\/j.vaccine.2013.07.050_bib0375","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.ijpara.2005.08.010","article-title":"Intranasal immunisation with a 62kDa proteinase combined with cholera toxin or CpG adjuvant protects against Trichomonas vaginalis genital tract infections in mice","volume":"35","author":"Hern\u00e1ndez","year":"2005","journal-title":"International Journal for Parasitology"},{"issue":"1","key":"10.1016\/j.vaccine.2013.07.050_bib0380","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00436-010-2078-5","article-title":"Trichomonas vaginalis 62kDa proteinase as a possible virulence factor","volume":"108","author":"Hern\u00e1ndez","year":"2011","journal-title":"Parasitology Research"},{"issue":"27","key":"10.1016\/j.vaccine.2013.07.050_bib0385","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1016\/j.vaccine.2011.04.046","article-title":"The safety evaluation of adjuvants during vaccine development: the AS04 experience","volume":"29","author":"Gar\u00e7on","year":"2011","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13010074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13010074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T23:42:38Z","timestamp":1715816558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13010074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":77,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0264410X13010074"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.07.050","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current status and prospects for development of a vaccine against Trichomonas vaginalis infections","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.07.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}